TrialJournal of gynecologic oncology2026

Chemotherapy plus camrelizumab for fertility preservation (NACI-F) in FIGO stage IB1 cervical cancer: a multicenter, single-arm, phase 2 trial.

Yingjie Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.